A team of Boston College researchers has demonstrated an unprecedented catalytic approach that enables concurrent control of multiple convergences and selectivities in intermolecular amination of ...
A team of Boston College researchers has demonstrated an unprecedented catalytic approach that enables concurrent control of multiple convergences and selectivities in intermolecular amination of ...
Randomized phase II study to evaluate treatment with induction therapy with nivolumab plus ipilimumab, followed by nivolumab with chemoradiotherapy versus standard of care with chemoradiotherapy for ...
For decades, concurrent control groups have served as a foundational element of nonclinical drug development. Yet the model is under pressure as scientific, regulatory and ethical expectations evolve.
ACORD at MRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK; Euan MacDonald Centre for MND Research, Anne Rowling Regenerative Neurology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results